SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001728117-23-000094
Filing Date
2023-07-20
Accepted
2023-07-20 16:01:04
Documents
16
Period of Report
2023-07-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K goss-20230719.htm   iXBRL 8-K 44665
2 EX-4.1 goss-2023x07x19exx41.htm EX-4.1 123488
3 EX-10.1 goss-2023x0719xexx101.htm EX-10.1 302320
4 EX-99.1 goss-2023x0719xexx991.htm EX-99.1 14686
8 image_0.jpg GRAPHIC 17158
  Complete submission text file 0001728117-23-000094.txt   732354

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT goss-20230719.xsd EX-101.SCH 1913
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT goss-20230719_lab.xml EX-101.LAB 23834
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT goss-20230719_pre.xml EX-101.PRE 12516
10 EXTRACTED XBRL INSTANCE DOCUMENT goss-20230719_htm.xml XML 2716
Mailing Address 3013 SCIENCE PARK SAN DIEGO CA 92121
Business Address 3013 SCIENCE PARK SAN DIEGO CA 92121 (858) 922-0718
Gossamer Bio, Inc. (Filer) CIK: 0001728117 (see all company filings)

IRS No.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38796 | Film No.: 231099719
SIC: 2834 Pharmaceutical Preparations